171 related articles for article (PubMed ID: 26739889)
1. Deleting the TGF-β receptor in proximal tubules impairs HGF signaling.
Nlandu Khodo S; Neelisetty S; Woodbury L; Green E; Harris RC; Zent R; Gewin L
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F499-510. PubMed ID: 26739889
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
3. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN; LaPage J; Hirschberg R
Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
[TBL] [Abstract][Full Text] [Related]
4. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
6. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E
Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
Iekushi K; Taniyama Y; Kusunoki H; Azuma J; Sanada F; Okayama K; Koibuchi N; Iwabayashi M; Rakugi H; Morishita R
Hypertension; 2011 Aug; 58(2):190-6. PubMed ID: 21670418
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
Mou S; Wang Q; Shi B; Gu L; Ni Z
Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
[TBL] [Abstract][Full Text] [Related]
9. Blocking TGF-
Nlandu-Khodo S; Neelisetty S; Phillips M; Manolopoulou M; Bhave G; May L; Clark PE; Yang H; Fogo AB; Harris RC; Taketo MM; Lee E; Gewin LS
J Am Soc Nephrol; 2017 Dec; 28(12):3490-3503. PubMed ID: 28701516
[TBL] [Abstract][Full Text] [Related]
10. Transient reciprocal change of renal hepatocyte growth factor and transforming growth factor-beta1 may relate to renal hypertrophy in rats with liver injury or unilateral nephrectomy.
Tsau YK; Tsai IJ; Chen YM
Pediatr Res; 2006 Apr; 59(4 Pt 1):494-9. PubMed ID: 16549518
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice.
Inoue T; Okada H; Kobayashi T; Watanabe Y; Kanno Y; Kopp JB; Nishida T; Takigawa M; Ueno M; Nakamura T; Suzuki H
FASEB J; 2003 Feb; 17(2):268-70. PubMed ID: 12475893
[TBL] [Abstract][Full Text] [Related]
12. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.
Bhowmick NA; Chytil A; Plieth D; Gorska AE; Dumont N; Shappell S; Washington MK; Neilson EG; Moses HL
Science; 2004 Feb; 303(5659):848-51. PubMed ID: 14764882
[TBL] [Abstract][Full Text] [Related]
14. Deleting the TGF-β receptor attenuates acute proximal tubule injury.
Gewin L; Vadivelu S; Neelisetty S; Srichai MB; Paueksakon P; Pozzi A; Harris RC; Zent R
J Am Soc Nephrol; 2012 Dec; 23(12):2001-11. PubMed ID: 23160515
[TBL] [Abstract][Full Text] [Related]
15. Influenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells through HGF/c-Met and TGF-α/EGFR signaling.
Ito Y; Correll K; Zemans RL; Leslie CC; Murphy RC; Mason RJ
Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(11):L1178-88. PubMed ID: 26033355
[TBL] [Abstract][Full Text] [Related]
16. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors.
Kumamoto H; Yoshida M; Ooya K
J Oral Pathol Med; 2002 Oct; 31(9):539-48. PubMed ID: 12269993
[TBL] [Abstract][Full Text] [Related]
18. Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion.
Uyttendaele H; Soriano JV; Montesano R; Kitajewski J
Dev Biol; 1998 Apr; 196(2):204-17. PubMed ID: 9576833
[TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression.
Li Y; Spataro BC; Yang J; Dai C; Liu Y
Kidney Int; 2005 Oct; 68(4):1500-10. PubMed ID: 16164627
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.
Liu Y; Tolbert EM; Lin L; Thursby MA; Sun AM; Nakamura T; Dworkin LD
Kidney Int; 1999 Feb; 55(2):442-53. PubMed ID: 9987069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
